Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? (2019)
- Authors:
- USP affiliated authors: MONTANARI, CARLOS ALBERTO - IQSC ; LEITÃO, ANDREI - IQSC ; CIANNI, LORENZO - IQSC
- Unidade: IQSC
- DOI: 10.1021/acs.jmedchem.9b00683
- Assunto: NEOPLASIAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2019
- Source:
- Título: Journal of Medicinal Chemistry
- ISSN: 0022-2623
- Volume/Número/Paginação/Ano: v. 62, n. 23, p.10497-10525 july, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
CIANNI, Lorenzo et al. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity?. Journal of Medicinal Chemistry, v. 62, n. 23, p. 10497-10525 july, 2019Tradução . . Disponível em: https://doi.org/10.1021/acs.jmedchem.9b00683. Acesso em: 26 dez. 2025. -
APA
Cianni, L., Feldmann, C. W., Gilberg, E., Gütschow Michaell,, Juliano, L., Leitão, A., et al. (2019). Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? Journal of Medicinal Chemistry, 62( 23), 10497-10525 july. doi:10.1021/acs.jmedchem.9b00683 -
NLM
Cianni L, Feldmann CW, Gilberg E, Gütschow Michaell, Juliano L, Leitão A, Bajorath J, Montanari CA. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? [Internet]. Journal of Medicinal Chemistry. 2019 ; 62( 23): 10497-10525 july.[citado 2025 dez. 26 ] Available from: https://doi.org/10.1021/acs.jmedchem.9b00683 -
Vancouver
Cianni L, Feldmann CW, Gilberg E, Gütschow Michaell, Juliano L, Leitão A, Bajorath J, Montanari CA. Can Cysteine Protease Cross-Class Inhibitors Achieve Selectivity? [Internet]. Journal of Medicinal Chemistry. 2019 ; 62( 23): 10497-10525 july.[citado 2025 dez. 26 ] Available from: https://doi.org/10.1021/acs.jmedchem.9b00683 - How NEQUIMED/IQSC/USP’s using machine learning to aid drug discovery
- Mapping the S1 and S1’ subsites of cysteine proteases for the synthesis of new dipeptidyl nitriles as trypanocidal agents
- Planejamento molecular baseado na estrutura do ligante
- Desenvolvimento de fármacos
- Proteolytic activity inhibition inside the living cells from leishmania species by Dipeptidyl nitriles derivates
- Targeting the Shc-EGFR interaction with indomethacin inhibits MAP kinase pathway signalling
- In silico selection and cell-based characterization of selective and bioactive compounds for androgen-dependent prostate cancer cell
- On the study of halogen bond interaction to increase cruzain affinity of covalently boundd reversible inhibitors
- Ligand efficiency metrics considered harmful
- The São Carlos Special Medicinal Chemistry Meeting - SancaMedChem
Informações sobre o DOI: 10.1021/acs.jmedchem.9b00683 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
P18280.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
